Incyte Corporation (INCY)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
79.86-2.58 (-3.13%)
As of 3:49 PM EDT. Market open.
People also watch:
VRTXBMRNMYGNALXNREGN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open82.45
Prev Close82.44
Bid80.02 x 200
Ask80.09 x 300
Day's Range78.71 - 85.07
52wk Range55.00 - 133.62
1y Target EstN/A
Market Cap15.01B
P/E Ratio (ttm)217.01
Beta0.65
Volume1,441,165
Avg Vol (3m)1,120,825
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Business Wire8 hours ago

    Forbes Magazine Names Incyte to its List of World’s Most Innovative Companies for Second Consecutive Year

    Incyte Corporation today announced it has been ranked 4th on Forbes magazine’s 2016 list of the World’s Most Innovative Companies. Incyte, a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, is advancing an innovative and diverse portfolio of large and small molecules comprised of 14 development candidates against 11 different molecular ...

  • Biotech Stocks Seesaw As M&A Hopes Meet New Pricing Fears
    Investor's Business Daily23 hours ago

    Biotech Stocks Seesaw As M&A Hopes Meet New Pricing Fears

    The biotech group hit a seven-month high Wednesday before reversing after Hillary Clinton attacked drug pricing again.

  • optionMONSTERyesterday

    Call buyers betting on rebound in Incyte

    Traders are betting that Incyte will rally in coming weeks. optionMONSTER's tracking program detected the purchase of more than 2,200 September 90 calls for $1.50 to $3.40 today. Volume surpassed open ...